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ABSTRACT
The purpose of this study was to determine the effect of exercise training alone
and in a model of Type 1 Diabetes Mellitus (T1DM), on Heat Shock Protein (HSP) and
Nitric Oxide Synthase (NOS) expression in entorhinal adjacent large and small cerebral
vessels. Thirty-two rats were randomly allocated to four groups: control sedentary (C),
control exercised (CX), diabetic sedentary (D) and diabetic exercised (DX). Exercise
training incorporated 5 days/week on a motorized treadmill (27m/min; 6 degree incline; 1
hour) for 10 weeks. Exercise trained groups had significantly greater Hsp70 expression
than their respective non-trained groups (p<0.05) and this response was not blunted in
T1DM animals. The inducible NOS (iNOS) expression was greater in diabetic sedentary
when compared to all other groups (p<0.001). Co-localization of protein with smooth
muscle cells illustrates that all HSP and NOS signal content is localized to the smooth
muscle area (SMA).

Keywords: cerebral vessels, exercise, type 1 diabetes mellitus, Heat shock protein 70,
inducible nitric oxide synthase
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CHAPTER 1
1.1 Introduction
Exercise is a physiological stressor that partially protects against a multitude of
biological stressors which impose deleterious consequences on cellular and tissue
homeostasis. Hence, exercise interventions are becoming increasingly important as they
have been illustrated to function as a critical preventative and potential therapeutic tool
under a variety of conditions. Indeed, aerobic exercise training is neuroprotective in an
assembly of diseases that include but are not limited to brain ischemia tolerance in the
event of ischemic stroke.
Strokes are the second leading cause of death worldwide. According to the
American Heart Association, ischemic stroke accounts for 87% of the incidents while
hemorrhagic and transient ischemic attacks (TIA) account for the remaining 13% (36,
62). Although exercise may limit the likelihood of and/or damage caused by stroke the
exact mechanism(s) as to how exercise exerts its benefits is not well understood (14, 16,
17).

However, the biological networks that elicit exercise-induced protection are

complex. However the role of chaperone proteins in cellular stress response has been
linked to stroke injury protection (42, 56).
Exercise is a physiological stimulus that elicits a systemic stress response on a
multitude of molecular regulators (4, 18). A highly studied family of chaperone proteins
known as heat shock proteins (HSPs) encompass inducible members that are activated by
exercise stress such as the 70-kDA HSP (Hsp70) (28). Minor episodes of stress are
capable of eliciting this heat shock response (HSR) and thereby conferring protection in
the event of a major stressful event. In this regard, exercise pre-conditioning has been
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found to stimulate the HSR and induce Hsp70, which in turn prevents and rescues
extensive protein misfolding thereby building systemic and potentially brain ischemia
tolerance (81).

Subsequent research in experimental T1DM models hinted at over

expression-associated neuroprotection protecting and/or curbing the severity of focal and
global cerebral ischemia (68).

Exercise pre-conditioning increases brain ischemia

tolerance by inducing the HSR which in return helps improve recovery in diseases that
are susceptible to protein misfolding and inflammation .
Ischemic stroke prevalence has increased globally in conjunction with the
growing Type 1 Diabetes Mellitus (T1DM) epidemic. Epidemiological studies from the
American Stroke Association indicate a significantly high risk factor for ischemic stroke
in patients with T1DM regardless of age and the process of aging itself, independently
increases the prevalence of ischemic stroke (23, 62). T1DM related hyperglycemia may
cause endothelial dysfunction and accelerated atherosclerosis, notable precursors that
lead to ischemic stroke. Particularly, the inflammatory consequences and the ensuing
endothelial dysfunction exhibited in T1DM etiology have been associated with metabolic
shifts in nitric oxide (NO) and nitric oxide synthase (NOS) regulation (22, 63).

NO

balance is critical for cellular function and is maintained by physiological production of
NO by eNOS but can reach toxic levels due to the inducible NOS (iNOS) (22, 28, 45). In
the T1DM profile, there is a pattern of decreased NO bioactivity with decreased eNOS
content and in some cases, this observation is concurrent with an overproduction of proinflammatory iNOS (21, 32). In addition to the general protection against protein
misfolding conferred by Hsp70, this protein was recently shown to elicit an antiinflammatory effect through the inhibition of iNOS (1, 35). This chapter will provide an
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overview of the neuroprotective role of exercise pre-conditioning in cerebral health and
disease, with particular attention to heat shock protein regulation as a potential
mechanism conferring this protection. The overview will incorporate a perspective on
aerobic exercise training and the changes associated with T1DM on brain health with
emphasis on the Hsp70, Hsp90, iNOS and eNOS and how these respective protein
expressions are characterized in diabetes alone, and with exercise training interventions.
1.2 T1DM and the Progression of Cardiac and Vascular Consequences
According to the American Diabetes Association (ADA), T1DM although not as
prevalent as T2DM, remains a growing global concern (7). T1DM is an autoimmune
disorder caused by the immune mediated destruction of pancreatic β cells, resulting in an
significant decline in the production of insulin (58). Individuals with T1DM undergo
exogenous insulin therapy, however, long-term glycemic complications persist and
fluctuations between hyperglycemic and hypoglycemic states impose distress to daily
life. The Framingham study report from 1979 on diabetes and cardiovascular implications
established that patients with diabetes had a high prevalence of peripheral artery disease,
coronary disease, and strokes (33, 77). Diabetes itself is associated with impaired tissue
defense mechanisms that render the body vulnerable to various stressors. One such
stressor is oxidative stress, which potentially plays a significant role in diabetes related
complications (37).

Hyperglycemia and hypertension are two atherogenic factors

underlying T1DM macro- and micro- vascular complications that evolve to become
primary contributors to injurious cardiovascular events, stroke, or peripheral vascular
disease (52, 58). These atherogenic factors contribute to the development of oxidative
stress, an imbalance in nitric oxide bioavailability and the production of reactive oxygen
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species (ROS) that collectively contribute to endothelial dysfunction (ED) implicated in
T1DM induced stroke and cardiovascular complications (52, 58, 63).
1.3 Histological Perspectives on Cerebrovasculature
Blood vessels form an intricate network throughout the central and peripheral
system. The innermost layer of blood vessel, the tunica intima or endothelium, is the
immediate contact to the circulation and behaves as a selective barrier to constituents in
the blood. In the case of larger blood vessels, the endothelium is surrounded by a tunica
media layer of vascular smooth muscle cells (VSMC) that are responsible for
vasodilation and vasoconstriction (71, 74). Amongst other methods, the endothelium
governs vasodilation through nitric oxide synthesis and vasoconstriction through the
synthesis of endothelin (74). In peripheral circulation, blood vessels supply tissues with
nutrients upon cellular demand. Exercise creates an environment of high metabolic
demand and initiates physiological changes that include fluxes in oxidative stress, sheer
stress and changes in perfusion pressure that initiate vascular responses in order to divert
nutrients to the site of working muscles (29). The central nervous system circulation
varies from that of peripheral, because the brain requires a more constant blood flow.
Though exercise-induced vascular responses have been investigated in skeletal muscle
and myocardial vasculature, very little is known of the mechanisms or components
underlying molecular changes associated with exercise stress in cerebral vessels. In
T1DM, progressive metabolic instability leads to structural changes in the vessels and the
consequences lead to events of ischemic stroke (58). An aspect of therapeutic stroke
research is targeted towards post-stroke injury and attenuating the degree of injury. It is
illustrated that stroke induced inflammatory reactions in the vessel, is on such mechanism
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underlying prolonged post-stroke injury and evidenced by Kusaka et al. , who illustrated
underlying causes of prolonged post-stroke injury to a decreased reactivity of cerebral
arterioles during reperfusion (37).
The mammalian brain is sensitive to oxidative stress and this is evident in the
aged brain. With aging, significant and progressive increases in the level of oxidative
stress have been linked to the development of various neurodegenerative conditions such
as Alzheimer’s disease. Studies with a neurodegernative Alzheimer’s model have
indicated that the hippocampus and adjacent areas, experience vast changes with aging
and that they are particularly sensitive to stress due to a high regional concentration of
glucocorticoid receptors (3, 20).

In recent years Brown et.al established neuronal

expression of heat shock protein in rat brain, particular to the hippocampus and adjacent
the entorhinal cortex matter (9). A recent study has demonstrated a link between the aged
brain that exhibits the Alzheimer’s phenotype and that of a T1DM brain and have
postulated a potential glucoregulatory mechanism underlying the progression of
Alzheimer’s

etiology

(6).

Similar

investigations

to

the

aforementioned

neurodegenerative models have illustrated neuronal HSR in areas of the mammalian
cerebrum that were confined to the spinal cord, hippocampus and entorhinal cortex. The
latter two locales in the rat mid-brain have been the most susceptible to disease induced
neuronal loss including ischemic stroke (19, 60). Though tissue specific heat shock has
been identified in cerebral tissue, very little is known of the cerebrovascular response to
T1DM.
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1.4 Physiological Implications of T1DM and Stroke
There is growing evidence of end-organ injury in the central nervous system that
has been attributed to hyperglycemia mediated metabolic and endocrine disturbances (7).
These disruptions lead to structural shifts in vascular morphology and functional shifts in
cerebral blood flow (CBF), which collectively manifest to progressive atherosclerosis in
diabetes and may induce stroke (65, 75). The incidence of ischemic stroke is two to six
folds higher in patients with diabetes when compared to those without diabetes (77).
Diabetes affects the cerebrovascular circulation by increasing the risk of
intracranial

and

extra

cranial

atherosclerosis

(7,

46).

In

diabetic

cerebral

microvasculature, structural irregularities include decreased capillary density and
thickening of capillary basement membranes (5, 34). Preliminary data asserts
microvasculature injury appears to manifest prior to the onset of clinical symptoms,
however little else is characterized in the microvasculature to bolster these assertions (7).
More so than other organs, the brain requires continuous circulating glucose and
cerebral health is tightly managed by glucoregulatory control. The brain requires 1/5 of
the available oxygen uptake at rest for survival and CBF is tightly regulated to ensure
sufficient nutrient and oxygen delivery (61). In a normotensive state, CBF is relatively
constant and maintained at arterial blood pressure of 60 to 160mmHg in order to
circumvent fluctuations in perfusion, that could lead to a state of hypoxia or potentially
increase in intracranial pressure (55, 61). Cerebral autoregulation, a marked feature of
the developed mammalian brain, refers to the capacity of cerebral vessels to compensate
for and actively adjust any decrease in cerebral perfusion pressure by vasodilatation and
adjust for increased BP (55, 61) .
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The more functional disturbances associated with T1DM induced stroke include
hyperglycemia and hypertension mediated regional alterations in CBF (6, 10, 26).
Systolic blood pressure is a regulator of CBF and hypertension causes marked adaptive
changes in the CBF, which lead to increased brain vascular resistance and loss of the
physiological mechanism of autoregulation observed in T1DM (61, 65). T1DM patients
that experience hypertension also exhibit altered CBF, in particular an overall chronic
reduction in CBF (68). A chronic reduction of CBF carries increased risk factors for a
multitude of cerebrovascular diseases and it is clear that an absolute reduction in CBF is a
high risk factor for susceptibility to stroke (26). Brennan et.al established that chronic
hyperglycemia is associated with a reduction in global CBF (gCBF), the same effect
observed with acute hyperglycemia in animal models (5, 6, 21). Subsequent
investigations illustrated a more regional alteration in CBF and a linear relationship
between the degree of hyperglycemia and the decrease in gCBF (53, 70).
Endothelial dysfunction is an injurious vascular manifestation of hyperglycemia
and hypertension. The mechanism(s) by which ED arises is initiated by hyperglycemia
mediated imbalance in NO bioavailability and subsequent accumulation of ROS (58).
Specifically, toxic production of NO leads to an accumulation of superoxide anion (O2−)
and the subsequent formation of the ROS, peroxynitrite (ONOO−) (4, 22, 35).
Peroxynitrite is a potent oxidant that initiates substrate nitration and protein nitrosylation
which terminally attenuates the activity of eNOS (4). This reduced eNOS activity further
renders the vascular environment vulnerable to reduced NO-dependent vascular
responses and promotes key steps in vascular inflammation during stroke injury,
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including increased leukocyte adhesion to endothelial cells, recruited platelet aggregation
and underlying smooth muscle proliferation (58, 65).
During an ischemic event, inflammatory regulators contribute to and exacerbate
stroke injury (65). At the site of focal ischemia, there is an increased aggregation of
neutrophils, monocytes and transmigration of adhesion molecules, which subsequently
triggers cytokine signaling and recruits pro-inflammatory cytokines to the site. Cytokine
signaling recruits tumor necrosis factor α (TNFα), interleukin-1β (IL-1β), interleukin-6
(IL-6) and iNOS to the ischemic site and elevates the inflammatory response causing
exacerbated stroke injury. T1DM may exacerbate the sequelae of such ischemic events
leading to greater brain edema and larger infarct volume (36, 46).
Perturbations to NO regulation are detrimental to vascular homeostasis,
particularly endothelial function. It is known that physical activity enhances endothelial
function through adaptive changes in NO regulation, particularly through eNOS mediated
interactions (57).

NO is synthesized by three NOS isoforms that include neuronal

(nNOS, NOS-1), inducible NOS (iNOS, NOS-2) and endothelial NOS (e-NOS, NOS-3)
(22) .

NNOS is expressed in specific neurons in the CNS whereas iNOS, primarily

identified in macrophages, can be stimulated by cytokines in a variety of tissues,
especially in inflammatory disease (22). ENOS confers vascular protection throughout
the system via normostatic production NO which then allows the vasculature to carry out
physiological vasodilation, in optimal and sub-optimal stress conditions (18, 57). A
baseline level of NO is necessary for optimal vascular function, however toxic levels of
NO produced by iNOS, shifts the excess NO into a separate biological pathway resulting
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in an accumulation of superoxide anion and the production of harmful oxidants, such as
peroxynitrite (7, 57).
1.5 Exercise Physiology & Implications in T1DM
Physically active organisms have a better tolerance to various stressors when
compared to their sedentary counterparts, due to a progressive systemic pre-conditioning
(78). Exercise is a relatively minor physiological stressor which nonetheless may initiate
a stress response if the exercise intensity is sufficient (47). This may elicit protective
downstream adaptations that are cell, condition and system specific (8). These adaptive
responses are also specific to the exercise modality, intensity and duration (38, 48).
Aerobic exercise training has been illustrated to be beneficial for reducing all-cause risk
of premature death in populations highly susceptible to cardiovascular and
cerebrovascular diseases, including models of aging and T1DM (2,50,24). Exercise
preconditioning studies in ischemia-reperfusion models in the myocardium have
illustrated an exercise-training induced ischemia tolerance, or

attenuation of post-

ischemic consequences (49, 72). Likewise, there has been a progressive movement in
understanding the endogenous neuroprotective effect underlying brain ischemia tolerance
in models of ischemic stroke, reperfusion injury and recovery (81).
Neurodegenerative therapeutics have suggested a neuroprotective role of higher
intensity aerobic exercise training in potentially decreasing the risk, delaying the onset
and/or alleviating symptoms exhibited in a number of neurodegenerative diseases (2, 3,
10, 50, 69). According to research conducted in which the middle cerebral artery is
briefly occluded, (MCAO), the extent of cerebral consequence is shown to be directly
affected by the severity of ischemic insult and by the post-ischemic response, which
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includes activation of pro-inflammatory cytokines (36, 44).

Kitagawa et al. established

the phenomena of ‘brain ischemia tolerance’ wherein pre-conditioning events, such high
intensity exercise, attenuated post-stroke related injury (11, 81). The attenuated stroke
injury is a result of decreased activation of pro-inflammatory cytokines (such as Il-6 and
TNFα) and iNOS, in conjunction with an attenuated regional and significantly lowered
cerebral infarct volume (17, 41, 81). Ding et.al have demonstrated an aerobic exercisepreconditioning induced reduction in cerebral infarct volume and suggest this reduction
observed can be attributed to vastly improved post-stroke recovery mechanisms (13, 17).
Focal ischemia is initiated in the larger vessels however the mechanisms of stroke
induction and exercise-mediated neuroprotection remains unclear and have directed
current stroke research towards the core of microcirculation and vascular pathobiology.
Studies with MCAO induced stroke and observations of post-stroke reperfusion hinted at
the integrity of microcirculation as a determinant of the severity of consequences during
ischemic reperfusion and recovery (2, 17). Therefore, a further understanding of changes
in the vasculature would provide closer perspective on the potential mechanisms
underlying stroke injury and the effect of exercise training.
Various cerebrovascular diseases are characterized by marked changes in CBF, in
particular, a reduction of CBF (39, 61, 68). During exercise, the cardiovascular output is
actively modifying systemic vascular blood flow to working regions, however global
CBF (gCBF) is known to remain constant despite regional changes in CBF (39). Studies
assessing middle cerebral flow velocity (MCAv) using pulsed doppler ultrasound, in an
exercise training model, have illustrated a 10-25% increase in MCAv following exercise
training in aged adults (53). It is important to note that aging itself is characterized by
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chronic reductions in CBF. Consequently this response could be differently affected, in
which case exercise could bring CBF back to baseline conditions observed prior to the
onset of aging (55, 65).

Though MCAv is elevated post-training, gCBF remained

constant and unaffected by exercise in those particular investigations. Ainslie et al.
demonstrated that there was a change in gCBF when adjusted for varying exercise
intensities (55). With moderate intensity training, which equates to 60% VO2max , there
was marked elevation in gCBF (53, 55). In contrast, with higher intensity exercise where
VO

>60%, there is a significant decline in gCBF to baseline levels and during that

2max

window of heavy metabolic demand, it is postulated that transient hyperventilation
mechanisms take over for short-term metabolic demand (39, 55). The brain strives to
maintain its autoregulation, in which case high intensity aerobic exercise generally cannot
be maintained for extended durations. In some models of exercise training and induced
stroke, exercise-trained animals exhibit higher regional CBF during post-stroke
reperfusion and thus attenuated injury despite non-significant gCBF increases during
exercise training. Perhaps this indicates that there may be various physiological
adaptations of exercise training that contribute to the observed post-stroke protection
(43). The exact mechanisms as to how CBF is governed and adapts with exercise
training remains unclear.
1.6 Biological Basis of Heat Shock Proteins
The exact underlying mechanism(s) as to how exercise imposes ischemia
tolerance remains unclear, however research has recently been directed to the role of
stress response adaptations as a possible factor in this regard. Heat shock proteins (HSP)
are ‘evolutionarily conserved’ stress proteins that function as molecular chaperones and
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exhibit a cytoprotectant role during physiological insults, including diseases that incite
cellular stress. HSPs have also been widely studied for their anti-inflammatory role in
protection against cytotoxicity. HSPs are classified by their molecular mass, ranging from
the smaller HSP families such as Hsp27 to the larger HSPs that include Hsp70, Hsp60
and Hsp90. HSPs function as constitutive or inducible stress proteins that have
physiological importance that are condition and tissue specific (56, 76). The constitutive
HSPs are generally thought to engage in housekeeping roles while the inducible HSPs are
up regulated by a stress stimulus for directed cellular protection (56).
Under physiological conditions Hsps are primarily located in the cytoplasm and
bound to heat shock factors (HSFs), of which there are three variant transcription factors
in mammals (54).

When sufficient physiological stress leads to some protein

denaturation or damage, dissociation of HSPs from HSF occurs with subsequent nuclear
localization and stress protein induction occurs (54).
1.6.1 Molecular Basis of HSPs
Within the chaperones, the70-kilodalton (kDA) family of HSPS, Hsp70, has been
most characterized in exercise health and disease models (54, 76). The Hsp70 family of
proteins encompasses the constitutively expressed protein, Hsc70 (Hsp73), and its more
widely studied inducible counterpart, Hsp70 also known as Hsp70i and Hsp72 (54).
Researchers have long established the ubiquitous role of Hsp70 in the maintenance of
cellular homeostasis. Under normal physiological resting conditions, Hsp70 exists in low
quantities in most tissues, unlike the constitutive counterpart, Hsc70 (79). The
physiological benefits of Hsp70 overexpression have been established in a variety of
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systemic models.

Consequently, heat shock pre-conditioning induced elevations in

myocardial Hsp70 expression have been observed in conjunction with decreased
ventricular infarct damage post-ischemia (40, 49).

Further, Hayes et.al noted an

increased Hsp70 mRNA content was directly correlated with reduced area of cerebral
infarct following MCAO induced ischemic stroke (12).
The constitutively present 90-kDA heat shock protein, Hsp90, accounts for one of
the most abundant cytosolic proteins (63, 64).

Hsp90 functions as an interactive

housekeeping protein that ensures the maintenance of protein-folding and aggregation
and acts as a chaperone to many client proteins (59). Of particular interest, Hsp90 has
been demonstrated to interact directly with eNOS and thus mediate the intricate balance
between NOS, NO and superoxides (18, 69).

Hsp90 primarily behaves as a signal

transduction molecule. For example, it initiates phosphorylation of eNOS in order to
regulate vascular permeability and vasodilation (69).
1.6.2 Physiological Basis of HSPs and Exercise
The magnitude and duration of exercise stress plays a critical role in the stress
induction response such that, It is evident, the more demanding the exercise, the more
robust the HSP induction (48). With aerobic training, Harris et.al demonstrated a
sustained training-induced increase in Hsp70 levels in rodent striated muscle, whereas the
response was diminished in other Hsps studied. Data from Milne and Noble, illustrated
only high-intensity exercise training is sufficient to induce myocardial Hsp70 when
compared to lower intensity training(49). Physical activity induction of Hsp70 has not
been as actively investigated in the brain as systemic tissue, however Campisi et.al
demonstrated habitual exercise stress does induce a HSR and subsequent Hsp70 response
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in the various regions of the brain including hypothalamus, hippocampus and prefrontal
cortex alongside their respective adjacent areas (8). They postulated that the Hsp70
response could potentially be neuroprotective given observations from training studies in
skeletal muscle and myocardium (8)
Hsp90 is not as extensively characterized as Hsp70 in exercise training models.
Atalay et.al has observed no change in Hsp90 expression in vastus lateralis and red
gastrocnemius following an 8-week aerobic exercise training intervention, which can be
attributed to the specific type of muscle investigated (25). Other studies, did note an
increase in Hsp90 expression in the soleus muscles and vascular increase in eNOS
expression (25, 66). These observations are attributed to exercise mediated increases in
NO to allow for increased flow to working muscles, resulting in increased shear stress on
vascular wall (24). Hence, exercise induced changes in Hsp90 may be more associated
with the vasculature than the skeletal muscle fibers. No knowledge exists in the
cerebrovascular Hsp90 and eNOS expression following exercise training, however it can
then be assumed that Hsp90 and eNOS would respond differently in cerebrovasculature
when compared to skeletal muscle, in order to strictly regulate steady cerebral flow when
total cardiac output rises.
1.6.3 Physiological Basis of HSPs and Disease
A myriad of biological mechanisms have been under close scrutiny in an effort to
better understand the exercise mediated ischemic tolerance in stroke recovery (16). The
interaction between chaperone proteins HSPs and cellular stress response have been
fundamental constituents in understanding the pre-conditioning mediated cerebral
tolerance exhibited in stroke models.
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Hsp70 over-expression produces notable physiological benefits in many tissues.
More recently, it includes potential anti-inflammatory actions regulated by Hsp70.
Wieten et. al demonstrated Hsp70 up regulation with concurrent inhibition of
inflammatory cytokines that include TNFα and IL-6 (79, 82). Recent studies by Weiss
et.al have established that direct interaction between Hsp70 and an inhibitor of nuclear
factor kappa-B kinase subunit alpha (IKK-α), interrupts the activation of a master proinflammatory transcription factor nuclear factor kappa-light-chain-enhancer of activated
B cells (NF-κB) (43, 82).

Co-immunoprecipitation studies by Zheng et.al have

illustrated an Hsp70 mediated inhibition of NF-κB and associated NF-κB regulatory
genes that specifically include pro-inflammatory expression of iNOS (82). .
The stress response has a differential impact on constitutive proteins when
compared to their inducible counterparts. Variability in Hsp90 expression has been
implicated in regulation of oxidative stress in pathological conditions such as hypoxia
and preeclampsia (57, 63). In T1DM animal models, the progressive hyperglycemic state
appears to elicit a dissociation in the Hsp90 interaction with eNOS which has been
attributed to an increased interaction between Hsp-90-IKKβ and deactivation of eNOS
(63). In effect, increased Hsp90-IKK interactions allow for subsequent activation of
NFκB and the ensuing inflammatory and cytokine response while simultaneously
blunting NO signaling (51).
1.7 Nitric Oxide Synthase and HSPs
1.7.1 iNOS and Hsp70
Type one diabetes is a major risk factor for vascular dysfunction whereby altered
NO regulation and elevated oxidative stress leads to vascular inflammation and ischemic
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stroke. INOS is a pro-inflammatory protein, that upon induction serves as a primary
inflammatory agent, eliciting the synthesis of toxic levels of NO (35). Immune reactions
are mediated in part through activation of NF-κB through physiological stress (including
ischemia and oxidative stress), leading to an up regulation of downstream proinflammatory genes including iNOS (44). (Fig.1)

Under normal physiological

conditions, there exists low to no CNS expression of iNOS however during inflammatory
events, iNOS is induced by cytokines that include TNFα, Interferon gamma (IFNγ) and
Interleukin-1 beta (IL-1β) (30, 35).

This immunological response is observed and

exacerbated in T1DM brain, during ischemic stroke (43). Parmentier et.al demonstrated
the impact of exogenous administration of iNOS blockers on the reduction of postischemia cerebral infarct volume (44). Ross et.al illustrated a considerable reduction in
infarct volumes in an iNOS knockout mouse model compared to wild-type animals, when
subjected to a bout of cerebral ischemia (62).
Hsp70 is involved in adaptive and innate immune regulation which varies
according to the location of its induction and expression (82).

Intracellular

overexpression of Hsp70 in astrocytes has been noted to reduce inflammatory induction
of toxic levels of NO by iNOS (79). As mentioned, physiological levels of NO derived
from eNOS governs normal vasodilation in the system, however toxic levels of NO
oftentimes 10 times as much as eNOS produced by iNOS, results in peroxynitrite
formation and free radicals causing heightened oxidative stress. Hsp70 overexpression
directs an inhibition of inflammatory responses through deactivation of NF-κB and the
downstream NF-κB dependent pro-inflammatory component, iNOS (79, 80, 82). In
effect, Hsp70 elicits protection through inhibition of pro-inflammatory proteins that
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would otherwise compromise brain health in various conditions of inflammation.
Induced or transgenic overexpression of Hsp70 correlate to a significant reduction in
brain infarct volume following ischemic insult (41). The exact mechanism of this
antagonistic interaction, where an overexpression of Hsp70 is noted with a concurrent
down regulation of iNOS, is not entirely clear. Yenari et.al, implemented a transient
MCAO stroke model in transgenic mice exhibiting Hsp70 overexpression, through which
the preliminary data illustrated increased Hsp70 association with NF-κB and IκB during
reperfusion and recovery (79, 80).

This increased association then prevents

phosphorylation of IκB by IKK and consequently establishes the inhibition of NF-κB (51,
82). In doing so, Hsp70 overexpression illustrated to regulate the inhibition of NF-κB and
subsequent downstream inflammatory components. Data from Yenari et.al allude to an
Hsp70 mediated anti-inflammatory regulation and an inhibition of iNOS, which would
warrant further characterization of Hsp70 and iNOS in disease conditions that are
threatened by inflammatory consequences (80, 82).
1.7.2 eNOS and Hsp90
From its discovery, Hsp90 has been established as a regulator of varying signal
transduction pathways that include interactions with over 200 client proteins and 50 cochaperones, making it difficult to characterize its primary role (59). Investigations
evaluating more specific Hsp90 interaction with cellular constituents provide a better
understanding of the role of Hsp90 in health and disease. In the latter 1990s, Sessa et.al
introduced the biological association between Hsp90 and eNOS, whereby his team of
researchers demonstrated activation of eNOS upon binding with Hsp90 (63). In doing
so, Hsp90 interacts with eNOS and upon interaction Hsp90 is further recruited to the
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eNOS complex by surrounding molecular agonists (69). Vascular regulation relies on
eNOS, which governs blood flow, blood pressure and angiogenesis through physiological
NO production (63, 64).

Exercise training results in elevated systemic vascular eNOS

expression, localized to endothelium and VSMCs, in conjunction with increases in
concentration of NO (67). This is postulated to be due to exercise-induced shifts in
laminar flow and shear stress on the vasculature, in order to ensure adequate perfusion to
the working system.

From a T1DM perspective, Mohan et.al illustrated an IKKβ

interaction with Hsp90 and this interaction is augmented by hyperglycemia in cultured
vascular endothelial cells, in doing so this diminishes Hsp90 interactions with eNOS (51).
This diminished interaction is one possible mechanism that illustrates how severe
hyperglycemia may attenuate eNOS activation and expression, observed in the
progression of T1DM phenotype. Fig. 1.
1.8 The T1DM Insulin HSP Connection
Individuals with T1DM undergo exogenous insulin therapy, which incorporate
subcutaneous planted insulin pumps or repeated injections to maintain physiological
blood glucose concentrations (3). In the brain, insulin levels are governed by the
endothelial transport across the blood-brain barrier into the cerebrospinal fluid and
interestingly, the cerebral levels are noted to be independent of plasma insulin, however
systemic changes in circulating insulin still govern cerebral functions (3). Acute studies
noted a short-term insulin withdrawal lead to deleterious neurochemical changes in brain
and subsequent insulin replacement lead to complete or partial restoration of cerebral
function (6). Notably, T1DM is a condition that is initiated through an autoimmune
targeted elimination of pancreatic beta cells and or circulating insulin (3). Investigations
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using bacterial Hsp70 orthologs hint at the depletion of Hsp70 as possible mechanism to
the observed increase in epitope recognition by T cells and subsequent acceleration in the
immune-mediated progression of T1DM (73). With studies investigating diabetic
peripheral neuropathy (DPN) it is then postulated co-administration of other diabetic
treatment including heat shock inducers maybe perhaps improve or attenuate the
progression of DPN (73). Studies by Li.et al have illustrated an insulin mediated
induction of low-level vascular Hsp70 expression alluding to a possible shared signaling
pathway between Hsp70 and insulin (40).
1.9 Summary
T1DM is a risk factor for stroke, of which ischemic stroke accounts for 80-85% of
stroke incidence. Hyperglycemia mediated metabolic shifts such as an increase in
oxidative stress in the microcirculation, have been implicated as a mechanism by which
diabetes contributes to a significant increase in the risk for vascular dysfunction in the
brain. Epidemiological studies with exercise pre-conditioning in humans, have illustrated
increased brain ischemia tolerance correlated to a decrease in post-stroke injury and/or
the potential to decrease the prevalence of ischemic stroke. It has been illustrated that
exercise preconditioning stress confers neuroprotection from ischemic stress in
conjunction with an increased tissue HSP induction.

Of particular interest, Hsp70

overexpression has been attributed to the neuroprotection in conditions of both focal and
global ischemia. This overexpression of Hsp70 has been attributed to increased brain
ischemia tolerance and has also been linked to anti-inflammatory role, specifically an
Hsp70 mediated inhibition of NF-κB and iNOS. In models of health and disease, the
function of housekeeping regulation is oftentimes overlooked due to their highly
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regulated constitutive nature. However it is important to elucidate the interactions of
housekeeping proteins with secondary components.

Hsp90 interactions with eNOS

highlight the potential importance of protein-interactions in disease, explicitly the
progression of diabetes induced vascular dysfunction. Diabetes induced endothelial
dysfunction has been linked a decreased expression of eNOS and exercise training has
differentially affected this response in systemic tissues. Patients with T1DM, despite
exogenous insulin therapy, still experience progressive microcirculatory insults from
metabolic glycemic shifts. Pharmacological HSR inducers have recently become a
potential therapeutic thought however very little is still known of the cerebral heat shock
response and the characterization of diabetic stress in cerebrovasculature.

Exercise

training remains a viable potential therapeutic strategy for diabetes induced
cerebrovascular complications. Thus the objective of this study is to primarily evaluate
the effect of 10-weeks of high intensity aerobic training alone and in controlled to slight
hyperglycemic T1DM condition, on HSP and NOS expression in large and small cerebral
vessels. The co-localization of Hsp70, Hsp90, iNOS and eNOS proteins with vascular
smooth muscle cells, will in addition help elucidate morphological characterization of the
proteins of interest in cerebral vessels. It is hypothesized that a 10-week high intensity
training protocol will be associated with a long-term robust increase in Hsp70 expression
and T1DM could potentially blunt this training response observed in the trained only
group. Secondly, it is hypothesized that following diabetes induction with no exercise
training intervention, there will be an increase in iNOS expression in the sedentary
T1DM group. Lastly, it is hypothesized that exercise training will be associated with a
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relative increase in Hsp90 and eNOS expression, when compared to the non-trained
groups.
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Fig.1.1 Nitric Oxide Regulation in Diabetes
Green dashed encapsulation highlights eNOS bioactivity on endothelial dysfunction.
Yellow dashed encapsulation highlights NF-κB bioactivity with the downstream regulation of iNOS,
and how it all collectively contributes to the development of vascular inflammation.
Visual representation of the anti-inflammatory contributions of Hsp70 overexpression, through
inhibition of iNOS.
Figure adapted from Paneni et.al.2013(58)
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CHAPTER 2
2.1 Introduction
Strokes are the second leading cause of death worldwide and ischemic stroke
accounts for over 80% of the incidents (9). Epidemiological studies confirm a high risk
for ischemic stroke in patients with Type 1 Diabetes Mellitus (T1DM) (11, 31). T1DM
is an autoimmune disorder caused by the immune mediated destruction of pancreatic β
cells, resulting in an absolute decline in the production of insulin and in increased level of
circulating glucose (36). Hyperglycemia is a major atherogenic factor underlying the
macro- and microvascular complications of Type 1 diabetes that evolve to become
primary contributors to injurious cardiovascular events, stroke, or peripheral vascular
disease (28, 30). The majority of ischemic stroke incidents are a terminal causality of
endothelial dysfunction and accelerated atherosclerosis (17, 42).
Aerobic exercise is a physiological stressor, established as a preventative tool in
reducing risk factors for cardiovascular and cerebrovascular complications (7, 36).
Aerobic exercise training has been attributed to the neuroprotective phenomena of ‘brain
ischemia tolerance’ (38). It is suggested that pre-conditioning exercise stress builds an
adaptive tolerance in the brain by strengthening the recovery response post-ischemic
event and in effect attenuating the degree of cerebral damage observed (2, 38).
Exercise functions as a physiological stimulus which elicits a systemic stress
response that includes the heat shock response (HSR). This response has a downstream
impact on a hierarchy of molecular regulators, such as heat shock proteins (HSPs) (12,
29). HSPs are a family of chaperone proteins that are constitutively present and stress
inducible and which function as tissue-specific cytoprotectants against various
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pathological conditions. The inducible 70kDA HSP (Hsp70), is a stress induced
molecular chaperone that offers cardioprotection and is up-regulated with exercise (22,
26, 27).

Recently, these protective Hsp70 proteins have been found to increase in

skeletal muscle vasculature following exercise where they likely reduce oxidative stress
and protect endothelial integrity and vascular signaling (6, 26). In the brain, increased
Hsp70 tissue mRNA correlates to a reduced area of brain death, observed in a middle
cerebral artery occlusion (MCAO) stroke model (14, 20).

Studies in T1DM models,

hint at HSP associated neuroprotection against severe ischemic strokes whereby
overexpression of Hsp70 has been noted to curb the severity of focal and global cerebral
ischemia via attenuated post-stroke infarct volume (37, 39). In an experimental T1DM
model, Lappalainen et.al recently illustrated a blunted Hsp70 response in whole brain
tissue lysates following chronic exercise training in diabetic trained when compared to
non-diabetic trained (20). The distribution and up-regulation of Hsp70 in cerebral
vasculature is less clear, particularly following training and in chronic disease conditions
such as diabetes.
Hsp70 functions as part of a multi-chaperone complex with co-chaperones, such
as the 90kDA HSP(Hsp90). Hsp90 is a constitutively present cytosolic protein that
promotes the vasodilation of blood vessels via interactions contributing to the
phosphorylation of endothelial nitric oxide synthase (eNOS), which produces nitric oxide
(NO) to increase vascular permeability and promote vasodilation (13, 33). In a resting
state, Hsp90 is associated with eNOS. Upon stimulus of the cells from varying stressors
such as hormones, shear stress or statins, the association between the two proteins
increases, resulting in physiological NO production (13, 23). One of the hallmarks of
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Type I diabetes is reduced vascular function (5). However, it is unknown whether
changes in Hsp90 in the cerebral vasculature are negatively affected by diabetes. The
influence of exercise training on this protein in cerebral vasculature has not been
examined either (25). Previous studies, with chronic and acute aerobic training, noted an
increase in Hsp90 expression in the soleus muscles and vascular increases in eNOS
expression (25, 66). These observations suggest exercise mediated increases in NO to
allow for increased flow to working tissues (13, 21). Given the differing blood flow
changes that occur with exercise in the vasculature of skeletal muscle versus the brain,
the response of Hsp90 and eNOS to exercise training in the latter is unclear.
Endothelial dysfunction (ED) exhibited in T1DM has been linked with an
imbalance in NO content and concurrent shifts in nitric oxide synthase (NOS) regulation
(15, 16).

The NO balance is critical for cellular function and is maintained by

physiological production of NO by eNOS (10, 32). The onset of NO imbalance can be
attributed to toxic over-production of NO, by inducible NOS (iNOS) in which case iNOS
produces 10 times as much NO as eNOS derived NO. This overproduction stimulates
inflammatory cascades and shunts the excessive NO towards the formation of superoxide
anion (O2−) and the accumulation of the reactive oxygen species (ROS) and peroxynitrite
(ONOO−).

Peroxynitrite is a potent oxidant which initiates substrate nitration and

protein nitrosylation and terminally attenuates the activity of eNOS (4, 32). In T1DM
there is a decreased bioactivity of eNOS and in particular cases, that response is coupled
with an increase in iNOS bioactivity (1, 32). Mohan et.al demonstrated that Hsp90
interacts with an inhibitor of NF-κB, IκB kinase β (IKKβ) and that this interaction, which
is augmented by hyperglycemia in cultured vascular endothelial cells, diminishes Hsp90

33
interactions with eNOS (31). This diminished interaction between eNOS and Hsp90 is
one possible mechanism that explains the decreased eNOS bioactivity in T1DM. This
reduction may render the vascular environment vulnerable to reduced NO-dependent
vascular responses and promotes vascular inflammation during stroke injury(34).
Potential mechanisms underlying improved post-stroke recovery have been
attributed to exercise preconditioning mediated inhibition of pro-inflammatory factors
including tumor necrosis factor alpha (TNFα), nuclear factor κ B (NF-κB) and iNOS(8).
The overexpression of Hsp70 has been attributed an anti-inflammatory role, specifically
an Hsp70 mediated inhibition of NF-κB and its downstream factor, iNOS(1, 18, 40).
The purpose of this study is to evaluate the effect of 10-weeks of high intensity
aerobic training alone and in a controlled slight hyperglycemic T1DM condition, on HSP
and NOS expression in large and small cerebral vessels. The method evaluating the
hypothesis requires independent localization of Hsp70, Hsp90, iNOS and eNOS proteins;
thus the study will elucidate morphological localization of the proteins of interest in
cerebral vessels. It is hypothesized that a 10-week high intensity training protocol will be
associated with a significant increase in Hsp70 expression and T1DM could potentially
blunt this training response observed in the trained only group.

Secondly, it is

hypothesized that, following diabetes, there will be an increase in iNOS expression in the
sedentary T1DM group.

Lastly, it is hypothesized that exercise training will be

associated with a relative increase in Hsp90 and eNOS expression, when compared to the
non-trained groups.
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The findings of this study has the potential to direct further attention to the
exercise induced vascular protection that can be translated into interventions in chronic
diseases that include components of cerebral vascular pathology, such as T1DM.
2.2 Methods
Ethics approval
This study was approved by the Research Ethics Board of the University of
Western Ontario, which is in accordance with the guidelines of the Canadian Council on
Animal Care (Appendix B.1).
Animals
Sixty-four, 8-week old, male Sprague-Dawley rats were obtained from Charles
River Laboratories (St. Constant, QC, Canada). The animals were housed as cage pairs,
sustained on a 12-hour dark/light cycle at a constant temperature (20 ±1°C) and relative
humidity (50%) throughout the entirety of the experiment. All of the animals were
allowed access to standard rat chow and water ad libitum.
Experimental Groups
The rats were randomly divided into one of four treatment groups of eight animals
each.

The resulting groups are the following:

control sedentary (C; n=8), control

exercised (CX; n=8), diabetic sedentary (D; n=8) and diabetic exercised (DX; n=8).
(Figure 2.1)
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Experimental Procedures
Diabetes Induction and Insulin Implantation
To enable a more translational approach to studying T1DM, a recently established
model of controlled slight hyperglycemia with insulin was employed for this study (25).
This particular methodology incorporated multiple low-dose streptozotocin (STZ)
treatment for the immune induction of diabetes (35) with a clamping of blood glucose
levels to between 9 and 15mmol/L blood glucose (Appendix A1, A2). The multiple lowdose STZ induction of diabetes consisted of 5 consecutive days of intraperitoneal
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injections of STZ (20mg/kg), which was dissolved in a cocktail of citrate buffer (0.1M,
pH 4.5). The insulin therapy was provided by subcutaneous implantation of exogenous
insulin pellets (1 pellet; 2U insulin/day; Linplant, Linshin Canada, Inc., Toronto, Ontario,
Canada) (Appendix A2).
The disease state was confirmed with two measures of non-fasted blood glucose
(BG) ≥18mmol/L, following the 5-day induction of STZ. Subsequent injections were
conducted until the diabetic state was confirmed.

Insulin Dosage
The state of slight hyperglycemia (non-fasting BG 9-15mM range) in D and DX
animals was maintained throughout the study with insulin pellet adjustments. (Appendix
A2).
Following the completion of study, the dosage of insulin was measured by
multiplying the total number of pellets implanted by the units of insulin secreted per
pellet. The resulting measure was then individually divided by the animal’s body weight
to obtain the relative circulating insulin dosage.
Aerobic Exercise Training Protocol
Exercise training began 2 weeks after induction of diabetes in the diabetic animals
and at an age-matched time point for their sedentary controls. Rats were familiarized on a
motor-driven treadmill, the week prior to the onset of their 10-week training protocol.
The familiarization protocol consisted of 15 m/min for 5 minutes, 21 m/min for 5 minutes
and 27 m/min for 5 minutes. Puffs of air and tactile stimulation were used to encourage
the animals to run. The 10-week training regimen incorporated 60 minutes of running, 5
days a week and at exercise speeds of 27 meters per minute at a 6° incline. The intensity
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of the aerobic exercise, 27m/min was pre-determined to represent higher intensity aerobic
at approximately 70%-75% VO2max (35).

Experimental Measures
Body Weights, Blood Glucose, Blood Pressures
Body weights (BW) and blood glucose concentrations (BG) were measured at
week 1, week 6 and week 10 of the training period. Blood (approximately 50 ul drop)
was collected from the saphenous vein and blood glucose concentration assessed via the
Freestyle Lite Blood Glucose Monitoring System (Abbott Diabetes Care Inc.,
Mississauga, Ontario, Canada).
Exercise Temperatures
For the two groups of animals that underwent exercise-training, CX and DX, preand post-exercise rectal temperatures were taken at mid-point (Week 6) of training and at
the endpoint (Week 10). Additionally, endpoint rectal temperatures were collected from
sedentary groups, C and D.
Tissue Collection
At the end of the experimental period animals were anesthetized with urethane αchloralose and euthanized by exsanguination. Exercise-trained animals were anesthetized
72 hours following their last exercise session in order to avoid any acute exercise changes
in tissue morphology. Whole brains were extracted from the cranial cavity, placed in 4%
paraformaldehyde (PFA) (Fischer Scientific, Corp.), which was renewed daily for 3 days
and then placed in 70% ethanol for temporary storage.
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Tissue Processing
Prior to fluorescence immunohistochemistry, whole fixed brains were split
transversely and embedded in paraffin. The paraffin blocks were transversely cut in serial
10µm thick sections using a microtome (Microm HM33E, Leica). (Appendix A3)
Sections were mounted on frosted, poly-L-Lysine-coated, positively charged microscope
slides (VWR® Superfrost® Plus Micro Slide 48311-703, 25x75mm) and stored at room
temperature for Hematoxylin & Eosin (H & E) and fluorescence immunohistochemistry.
Each slide held two serial sections of the tissue in order to have negative controls.
Histochemical Stains
The vascular targets in this study included superior cerebellar vessels adjacent to
the entorhinal cortex. In order to observe and confirm histological structures of interest,
sections were deparaffinised (Leica autostainer XL) and stained with a hematoxylin
(H&E) protocol using a Leica autostainer XL (Leica ST5010). (Appendix A4)

In order to observe vessels versus adjacent nerve matter, sections were
deparaffinised and stained with Luxol fast blue overnight at 58°C, dehydrated in 95% and
100% clear alcohol, followed by two changes in xylene and cover slipped. (Appendix
A4)
Fluorescence Immunohistochemistry (IHC)
As per Maddahi et.al (24) sections were further analyzed using a 2-day,
immunohistochemical protocol.
Day 1: Sections were deparaffinised on the autostainer and antigen retrieved for 2
hours (Pick Cell 2100 with sodium citrate buffer [10mM sodium citrate, 0.05% tween-20,
pH 6.0]), following which the slides were transferred to glass coplin jars filled with
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phosphate buffered saline (PBS, 1M). Slides were then dried with Kimwipe and
individual tissue sections on the slide were circled with a grease pen (Calbiochem
ImmunoPen™, EMD Biosciences) and placed in humidity chambers. Slides were
blocked at room temperature with 10% goat serum in PBS for 1 hour. In the meantime,
primary antibodies were thawed at room temperature and assembled as cocktail dilutions
in 1% Tween-PBS (TPBS) goat serum, which allowed for co-localization of VSMC with
proteins of interest, Hsp70, Hsp90, iNOS and eNOS. The primary antibodies were
combined as follows:
Concentrations and combinations are detailed in Table 2.1:
Table 2.1: Antibody Dilutions
1° Antibody
Cocktails
Hsp70 + Smooth
Actin
Hsp90 + Smooth
Actin
iNOS + Smooth Actin

eNOS + Smooth
Actin

Antibody Identifier

Antibody Concentration

Hsp70 (SPA-812)

1:100

Smooth α actin (AB18147)

1:400

Hsp90 (AB13485)

1:400

Smooth α actin (AB18147)

1:400

iNOS (AB 15323)

1:100

Smooth α actin (AB18147)

1:400

eNOS 1:100 (BD610299)

1:100

Smooth α actin (AB18147)

1:400

Following blocking, slides were washed in PBS for three cycles of 5 minute increments
and dried with Kimwipes. One out of two possible tissue sections on every slide were
incubated with primary antibodies overnight at 4°celsius. The remaining section was
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incubated with 1% TPBS goat serum in the absence of primary antibodies in order to
function as a negative control to test for non-specific staining.
Day 2: The slides were washed in PBS for three cycles of 5 minute increments
and dried with Kimwipes, following which all sections were incubated with a cocktail of
secondary antibodies for 1 hour at room temperature.
Secondary Antibody Cocktail: Anti-mouse (Alexa Fluor®488 Goat Anti-Mouse
IgG, Invitrogen, 1:400) and anti-rabbit secondary (Alexa Fluor®594 Goat Anti-Rabbit
IgG, Invitrogen, 1:400) antibodies in 1% goat serum in T-PBS.
Following secondary incubation slides were washed in PBS for three cycles of 5
minute increments and dried with Kimwipes. For the purpose of fluorescent imaging,
slides were mounted with a fluorescent mounting medium (Prolong® Gold Antifade
Reagent containing DAPI, Invitrogen) containing 1% 4’, 6-diamidino-2-phenylindole
(DAPI), a fluorescent nuclear stain and then covered with glass cover slips (VWR®
SuperSlips™ Micro Cover Glasses, Rectangular, No. 1, 24 X 55mm, CA48382-128). In
order to maintain the fluorescent signal integrity and minimize photo bleaching, the slides
were stored in a slide folder at 4˚C until imaging. (Appendix A6)

Fluorescent Microscopy and Protein Abundance Acquisition
The fluorescent bright field microscopy was carried out on a Zeiss Axiovert S100
microscope and images were captured at 16X and 40X magnification, using Northern
Eclipse 6.0 (Empix Imaging Inc) software. The protein content/abundance signal for
Hsp70, Hsp90, iNOS and eNOS were extracted using Image J (NIH). Specifically,
protein content was determined by outlining the wall of the blood vessel of interest and
calculating the integrated pixel density (signal) (Appendix A7) and the same technique
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was used to determine the integrated pixel density for the negative control of the same
blood vessel. To obtain the relative protein density, the pixel density of the negative
control was subtracted from the pixel density of the experimental sample. The difference
in pixel density provided values that were used to indicate fluorescence signal intensity
and thus expression of protein. For the collection of data for both small and large vessels,
this procedure was repeated for four blood vessels from the same animal and averaged to
give a single value for the particular animal.

Smooth Muscle Area Calculations
For comparative analysis of vessel size and protein content, smooth muscle area
(SMA) was calculated for each vessel for which the protein content was calculated. These
SMA calculations allowed for protein content adjusted to the area. For SMA calculations,
two full length perpendicular diameters from the outer perimeter of each vessel were
averaged to obtain a diameter for the outer circle. Likewise, two perpendicular diameters
from the inner ‘endothelial’ perimeter of each vessel were averaged to obtain a diameter
for the inner circle. The area of the smaller circle area was then subtracted from that of
the larger circle in order to obtain the SMA for that specific vessel. (Appendix A8)

Data Analysis
For all statistical findings, the reports were performed using Sigma.Plot 11 (Systat
Software Inc.) statistical software. Body weight, blood glucose concentrations, arterial
blood pressures and insulin dosage values were compared across all groups using a twoway repeated measures analysis of variance (ANOVA). Rectal temperatures across the
exercise-trained groups were compared using a two-way ANOVA. Where necessary,

42
comparative pairwise analysis was performed using either Tukey’s or Dunn’s post-hoc
test with significance set at p<0.05. Protein signal content data (expression) from
fluorescent IHC, unadjusted or adjusted for SMA, were compared using a three-way
ANOVA across all four groups. Where necessary, comparative pairwise analysis was
performed using Fischer’s post-hoc test with significance set at p<0.05. A three-way
ANOVA was performed to evaluate the protein content with respect to potential
interactions between disease, exercise training and vessel size.

2.3 Results
Baseline Conditions
Body Weights: Over the course of the study, all animals across the groups gained
a significant amount of weight (p<0.05).

Compared to diabetic sedentary (D) and

diabetic exercised groups (DX), the control sedentary(C) and control exercised groups
(CX) had significantly greater body weights by the end of week 10 (p<0.05). There was
no significant effect of exercise on body weight. (Table 2.2)
Blood Glucose: Weekly blood glucose concentrations for diabetic groups, D and
DX post-diabetes induction, were significantly higher when compared to both control
groups, C and CX (p<0.05). There was no significant effect of exercise on blood glucose
concentrations. (Table 2.2)
Insulin Dosage: Total insulin dosage comparison within diabetic sedentary and
diabetic trained groups, D and DX, suggests that there was pattern of decreased
exogenous insulin dosage in DX however, the difference was not significant (p=0.061).
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Exercise temperatures: In the control exercised group (CX), post-exercise
temperatures were significantly elevated when compared to pre-exercise temperatures, in
both week 6 and week 10 measures (p< 0.001). (Table 2.3)
Effect of Diabetes and Training on Protein Signal Content & Localization
Visualization of large cerebral vessels and protein signal density in the cerebral
cortex is demonstrated across Control (C), Control Exercise (CX), Diabetic Sedentary
(D) and Diabetic Exercised (DX) groups (Plates 1,3,5,7).

In addition, the double

immunofluorescence was conducted in order to achieve co-localization of protein to
VSMCs across all groups. (Plate 2,4,6,8)
Hsp70: Overlay of protein to VSMCs illustrates Hsp70 signal density is primarily
localized to the SMA. (Plate 1,2) There is a main effect of training on Hsp70 expression
(p<0.05). The signal content was greater in larger vessels when compared to small
vessels. (Fig.2.2) When adjusted for SMA, there is still a main effect of training on
Hsp70 expression (p<0.001). (Fig.2.3)
Hsp90: Overlay of protein to VSMCs illustrates Hsp90 signal density is primarily
localized to the SMA. (Plate 3,4) There is no main effect of exercise in the Hsp90
expression (p>0.05). The signal content was greater in larger vessels when compared to
small vessels. (Fig. 2.4) There is a main effect of vessel size (p<0.05). When adjusted for
SMA, there is still no main effect of training on Hsp90 expression (p>0.05). (Fig. 2.5)
iNOS: Overlay of protein to VSMCs illustrates iNOS signal density is primarily
localized to the SMA. (Plate 5, 6)

There was a main effect of disease and training on

iNOS expression (p<0.05). The signal content was greater in larger vessels when
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compared to small vessels (Fig2.6). When adjusted for SMA, there is still a main effect
training and disease on iNOS expression (p<0.001). (Fig 2.7)
eNOS: Overlay of protein to VSMCs illustrates eNOS signal density is primarily
localized to the SMA. (Plate 7,8) There is no main effect of exercise in the eNOS
expression (p>0.05). The signal content was greater in larger vessels when compared to
small vessels (Fig 2.8). There is a main effect of vessel size (p<0.001). When adjusted for
SMA, there is still no main effect of training on eNOS expression (p>0.05). (Fig. 2.9)

Effect of Diabetes and Training on Smooth Muscle Area
Because vascular dysfunction may be associated with intima hypertrophy we
examined the SMA in large and small cerebral vessels across the experimental
conditions. There were significant differences in SMA when comparing small versus
larger cerebral vessels (Fig 2.10; p<0.001), however there were no significant differences
in SMA between groups (Fig 2.10; p>0.05).

45

Table 2.2. Baseline Body Weights, Blood glucose concentration and Insulin Dosage across control sedentary, control
exercised, diabetic sedentary and diabetic exercised groups.
Groups

Body Weights
(Kg)

Blood Glucose Concentrations (mm)

Insulin Dose
Dose/kg

Week
1

Week
6

Week
10

Week
1

Week
6

Week
10

Sedentary Control
(C)

381±20

486±40

546±48

4.5±0.38

4.6±0.45

4.0±0.40

Control Exercised
(CX)

354±24

447±28

510±36

4.26±0.27

4.0±0.45

3.9±0.34

Sedentary Diabetic
(D)

302±21*

422±25*

455±33*

10.8±3.4Ϯ

15.5±2.4 Ϯ

16.8±2.6 Ϯ

5.56±1.5

Diabetic
Exercised (DX)

307±26*

408±3*

429±21*

10.8±5.6 Ϯ

14.8±2.0 Ϯ

13.5±4.6 Ϯ

3.25±1.9

Values are mean (N=8) ± SD. BW: * indicates D, DX had significantly lower weights than C,CX (p<0.05) BG:Ϯ indicates D,DX
post-diabetes induction, had significantly higher BG than C,CX (p<0.05) Insulin Dose: non-significance p=0.061
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2.4 Discussion
Ischemic stroke is often a result of endothelial dysfunction and accelerated
atherosclerosis, conditions attributed to prolonged hyperglycemic exposure exhibited in
T1DM (21). Aerobic exercise training has been proven to elicit adaptive neuroprotection,
particularly through reduced brain injury, demonstrated in in vivo models of ischemic
stroke (12, 14). A heat shock response (HSR)-induced, anti-inflammatory mechanism has
been suggested as an underlying this neuroprotection (8, 9). Nevertheless, the biological
underpinnings of aerobic exercise training and HSP-mediated effect on the
cerebrovasculature are not well known, especially in chronic disease conditions such as
T1DM. Hence the purpose of this study was to evaluate the effect of 10-weeks of high
intensity aerobic training in a slight hyperglycemic T1DM condition, on vascular HSP
and NOS expression. The working hypothesis fittingly afforded the morphological
localization of these proteins in cerebral vessels following exercise.
Fluorescent co-localization of protein overlaid with VSMCs illustrates that the
Hsp70, Hsp90, iNOS and eNOS expression is primarily localized to the SMA. These
observations are similar to those of Kim et.al (26), whereby heat shock stress induced
Hsp70 expression in mice aortic vascular smooth muscle cells. Through co-association
and localization of Hsp90 in the mesenteric tissue, Sessa et.al (40,41) determined Hsp90
is primarily localized to vascular smooth muscle cells as well (46, 47).

The present

study suggests that the vascular localization of HSPs in cerebral vessels is similar to those
in the systemic vasculature. For iNOS and particularly eNOS signal content, though the
signal is primarily localized to SMA there may be a tendency towards vascular
endothelial expression though this study does not confirm this assumption.

The
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observations of this study are in line with a study by Sun et al. (43) which evaluated the
effects of different exercise modalities on vascular localization of eNOS and iNOS in the
murine aorta (50). Their study confirmed endothelial and primarily perivascular
(surrounding smooth muscle) localization of eNOS and iNOS in endurance trained rat
aortic sections.
At a first glance, these results illustrate the capacity for cerebral blood vessels to
induce a HSR. This is the first study to examine the expression and localization of HSPs
in cerebral vessels. Previous studies have demonstrated Hsp70 induction in brain tissues
with chronic exercise training but this is the first study to demonstrate a cerebrovascular
localization of Hsp70 following aerobic high intensity training (3,27). Ten-week, high
intensity training alone (CX) and in T1DM rats (DX), induced a significant Hsp70
expression in both small and large vessels when compared to their respective non-trained
groups(C, D). The training induced Hsp70 expression was not blunted in the controlled
slight hyperglycemic, insulin treated T1DM model that we employed. These results are
in contrast to a previous rat diabetic model that illustrated a blunted training effect on
whole brain Hsp70 protein content (28). However, it should be noted that the previous
study sustained diabetes at a higher grade of hyperglycemia (>20mmol/L), in the absence
of exogenous insulin when compared to slight hyperglycemic model used in the present
study (9-15mmol/L). The presence of insulin appears to greatly affect the response of the
animals for a variety of measures (34). For instance, Li.et al. (24) have illustrated an
insulin mediated induction of Hsp70 expression in myocardial tissue. Thus, the Hsp70
expression observed in trained diabetic animals could be a synergistic effect of lower
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grade hyperglycemia maintained in this study and insulin mediated low-level induction of
Hsp70.
In the present study, both Hsp90 and eNOS expression remained constant in
trained (CX, DX) and untrained (C, D) groups, across both small and large cerebral
vessels. This observation is interesting in that, prior investigations have illustrated an
increase in skeletal muscle Hsp90 and eNOS protein content to facilitate an increase in
blood flow to working muscle (4,7). Yamaguchi et al. also noted that whole brain Hsp90
content remained unchanged in from the control to the diabetic state however there is no
clear interpretation of this result (44). To our knowledge, this study is the first to
investigate the vascular Hsp90 expression in the brain from exercise trained animals. The
brain is a unique organ that tightly regulates its vasodilatory mechanisms which may in
part explain the unaltered expression of Hsp90 across varying conditions.

In the

normotensive state, Hsp90 is associated with eNOS, and upon stimulation by various
factors, including exercise, the association between the two proteins increases, resulting
in baseline NO production which in turn, promotes vasodilation (15, 51). In the brain,
CBF is tightly autoregulated, unlike in skeletal muscle where there are large variations in
blood flow that occur in response to exercise (40, 42). Moderate intensity training, 60%
VO2max, induces a marked elevation in global CBF (gCBF) during exercise. In contrast,
with high intensity training (VO2max >60%), there is a significant decline in gCBF to
baseline level during exercise, despite a significant increase in metabolic demand. It is
then postulated that short-term hyperventilation sustains cerebral function under these
circumstances (42). It can then be suggested that in our study with higher intensity
exercise in the brain, there were no significant differences in vascular Hsp90 and eNOS
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protein content across all groups (C,CX,D,DX) conceivably due to an intrinsically tight
autoregulation that strives to keep vasodilatory mechanisms as constant as possible.
In this study the cerebrovascular iNOS protein content in sedentary diabetic
animals (D) was significantly greater than all other groups, in both small and large
vessels. These data agree with studies that have illustrated cerebrovascular iNOS up
regulation during pro-inflammatory events that include cerebral ischemia, and this up
regulation is site specific to the cortical region of ischemia in acutely stressed rats (33,
57). Since it has been reported (33) that iNOS is not present in the CNS under normal
conditions, this observation identifies a propensity towards cerebrovascular inflammation
even in moderate insulin treated hyperglycemic conditions. The most intriguing result is
the normalization of vascular iNOS content observed in trained T1DM animals (DX)
when compared to sedentary T1DM (D).
Exercise stress induces an HSR which in turn helps initiate an anti-inflammatory
milieu (3, 17). It has been postulated that upstream overexpression of Hsp70 imposes
downstream inhibition of iNOS and prevents the subsequent accumulation of high iNOS
protein levels in various organ tissue lysates including brain (24, 25). A proposed
underlying mechanism to this Hsp70 prompted protection is Hsp70 inhibition of NF-κB
via of its interaction with the NF-κB inhibitor I-κB.
With specific reference to eNOS, in this study there were no significant
differences in eNOS protein content between groups, particularly between T1DM and
non-T1DM groups. In contrast to prior studies illustrating a significant decrease in eNOS
bioactivity and accumulation in VSMCs, this study observed a minute overall decrease in
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the T1DM groups when compared to sedentary and trained non-T1DM groups but these
data were non-significant. One possible explanation could be the exogenous insulin and
attenuated degree of hyperglycemia (<20mmol) in this study, wherein the previous
studies by Mohan et,al (37) maintained higher grade

or ‘severe’ hyperglycemia

(>25mmol). The collective data from iNOS and eNOS in this model of T1DM depicts a
story whereby the progression of vascular inflammation precedes the phenotypic onset of
endothelial dysfunction.
The midpoint and endpoint temperature data in brief illustrate a non-significant
increase from pre to post temperatures in diabetic trained animals (DX) when compared
to significant increases from pre to post observed in trained animals (CX). In addition,
diabetic animals experienced higher pre exercise temperature measures when compared
to their non-diabetic trained counterparts. This observation in part could explain for the
HSP expression observed in diabetic animals in this study and could also be a factor of
disease induced symptoms that distort thermoregulatory mechanisms. This speculative
distortion could then have various downstream impacts on HSP expression however, the
exact mechanisms are not clearly understood at this point.
The vascular signal intensity was adjusted for SMA in small and large cerebral
vessels, in order to determine if and any potential impact of vessel size existed on the
individual protein expression. The SMA alone did not change between the four groups in
small or large vessels, with factors of disease (D) and training interventions (DX, CX)
when compared to sedentary (C). We had examined this because previous data suggested
that diabetes was associated with vascular hyperptrophy (4, 52). The fact that we did not
observe any change in SMA in the present investigation likely underscores the fact that
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we were using a controlled low-grade hyperglycemia diabetic model rather than an
untreated diabetic animal.

The short duration of the study, given that vascular

hypertrophy manifests at a more progressive stage of T1DM may have also been a factor.
Though the pattern of expression was similar in small and large vessels across all four
proteins of interest, when adjusted for SMA, Hsp90 and eNOS signal content had a main
effect of size. The Hsp90 and eNOS protein content was significantly greater in smaller
vessels when compared to larger vessels, prominent more so with eNOS expression.
These observations are similar to recently published data from our lab, where Murias et.al
(32) demonstrated greater eNOS protein content in smaller vessels, femoral arteries,
when compared to large branches of vessels such as the iliac artery and the descending
branch of aorta from in trained and untrained diabetic rats (38). In that study, a greater
concentration of eNOS protein in smaller vessels was implicated in the faster rate of
vasorelaxation observed in femoral when compared to the larger aorta and iliac. Hsp90
signal density was greater in smaller vessels than larger vessels, and the size effect was
significant, indicating that Hsp90 maintains a pattern of bioactivity parallel to that of
eNOS in the cerebrovasculature. In addition, the SMA adjustments denote the importance
of quantifying the signal content to area in order to gage a more normalized expression
factoring in the size.
2.5 Conclusion
Until now, no observations exist on cerebrovascular HSP and NOS expression in
a controlled low-grade hyperglycemic, insulin treated diabetes model and especially that,
with chronic exercise training intervention. The objective of this study was to evaluate
the effect of 10-weeks of high intensity aerobic training alone and in a slightly
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hyperglycemic T1DM condition, on HSP and NOS expression and concomitant
localization in cerebral vessels. Although animal models have frequently been employed
to study the effect of exercise on T1DM, the severity of hyperglycemia in those particular
models have imposed high levels of physiological stress such that, the results are difficult
to translate (7). In fact, blood glucose levels in these animals have been well above the
normal limits observed in human patients. In the present study, we attempted to mimic a
low level of hyperglycaemia often found in humans, even in the presence of insulin
supplementation (34). Hence this study has more translational relevance.
The results supported the hypothesis that a 10-week high intensity training
protocol would be associated with a significant increase in Hsp70 in control exercised
animals (CX); however, this response was not attenuated or blunted as expected in the
exercise trained diabetic group (DX). Interestingly, 10-week training protocol in the
diabetic group significantly blunted pro-inflammatory iNOS protein content when
compared to the increase in the pro-inflammatory iNOS observed in diabetic sedentary
group (D). This suggests that although many vascular properties, such as SMA, may be
well maintained when insulin is present and hyperglycemia is moderate, markers of
chronic cerebrovascular inflammation are still present. Importantly, exercise training
appears to mitigate this response even in the presence of reduced circulating insulin and
unaltered blood glucose levels. It is likely that elevations in vascular Hsp70 subsequent
to exercise training may protect against the progression of atherosclerosis and potentially
stroke by inhibiting iNOS and subsequent vascular inflammation (17, 54). This warrants
further study into the direct interactions between Hsp70 and pro-inflammatory regulators,
in order to address and advance towards potential therapeutic strategies.
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The results for Hsp90 and eNOS are in not in concurrence with our hypothesis, in
that there were no significant differences in vascular Hsp90 and eNOS protein content
amongst groups. We speculate that this can be attributed to an intrinsically tight cerebral
autoregulation that strives to keep vasodilatory mechanisms stable in addition to the
model of T1DM implemented in this translational approach. The outcomes of this study
have touched upon the HSP expression underlying exercise induced vascular protection
and merits future investigations in HSR regulation that can be translated into
interventions in chronic diseases that include components of cerebral vascular pathology.
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CHAPTER 3

3.1 Limitations and Assumptions

This study sought to investigate a unique concept of cerebrovascular HSP and
NOS expression, whereby the novelty of the subject made it difficult to interpret all
results with complete assurance. This is mostly due to the lack of previous studies
implementing a more physiological T1DM model, such as this study whereby exogenous
insulin therapy afforded a more controlled low-grade hyperglycemia.

In addition, there

exists a lack of interventions examining chronic high intensity exercise training alone
and in a T1DM model, on cerebrovascular HSP and NOS expression.

Having said that, there are considerations that could reinforce the results and these
considerations include directed characterization of molecular regulators and client
proteins of the HSPs studied. In particular, the speculative discussion around Hsp70 and
iNOS could be clarified with characterization of intermediate regulators, including NFκβ, I-κβ and TNFα.

A closer look at the molecular interactions, perhaps in situ

hybridization or immunoprecipitation assay protocols could highlight more precise
interactions between Hsp70 and the aforementioned pro-inflammatory regulators.

In

effect these assays would bolster the speculations about the anti-inflammatory role of
Hsp70 interactions with downstream factors, including in this study iNOS. By extension,
evaluating direct interactions between Hsp90 and its clients, including eNOS, IKKβ by
means of immunoprecipitation assays could highlight how this housekeeping protein
regulates between disease and non-disease states.
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Recent applications of in vivo research has shifted towards genetic manipulations
that target studying specific proteins of interest through transgenic knock out and knock
down models.

The transgenic knockout/knockdown or overexpression of (Hsp70+/-),

(Hsp70 -/-) in recent studies have elucidated many regulatory functions of Hsp70 and
future studies could potentially investigate and extract the precise role of Hsp70 in this
model and clarify if Hsp70 is a primary player in the observed neuroprotection.

The experimental results are speculations that could be bolstered with cerebral
blood flow (CBF) measures which were not taken into account for the experiment design
in this study. CBF measures could potentially shed light on the functional changes,
particular following exercise training and the response to lower grade hyperglycemia in
the cerebrovascular setting. CBF data would contribute to elucidating the flow mediated
influence on vascular shifts that would better explain the observed results, particularly
with Hsp90 and eNOS.
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APPENDIX A
A1. Streptozotocin induction protocol
REVISION DATE: 13/06/2012
PURPOSE:
To induce Type I diabetes in rats
MATERIALS:
Gloves
Lab Coat
Streptozotocin (STZ)
5X Stock Citric Acid/Citrate Buffer
Anhydrous Citric Acid
Sodium Citrate Dihydrate
MilliQ Deionized Water
13M HCl
3 Falcon Tube
Sterile Filter
EQUIPMENT:
Biological Safety Cabinet
Weigh Scale
pH Meter
PROCEDURE:
Preparing 5X Citric Acid/Citrate Buffer
1. For a pH 4.6 buffer at 765 mM (5X stock solution), in a beaker, Add
i. 13.8g Anhydrous Citric Acid (Sigma) or 15.1g Citric Acid Monohydrate
ii. 23.8g Sodium Citrate Dihydrate (Sigma)
Mix into iii. 175mL of MilliQ water
The pH should be at 4.6, Add HCl or NaOH to adjust (do not over-shoot pH)
2. Once the proper pH is obtained, add MilliQ water until you are close to the 200 ml
mark (pH will move slightly). If satisfied with the pH, adjust volume in a 250 ml
graduated cylinder and filter in a 0.2µm filter.
3. Store at room temperature. This is your 5X stock solution.
Making up Streptozotocin (STZ) for Injection
**NOTE Animals should be pre-weighed prior to making up STZ to ensure accurate
amounts of STZ to be prepared.
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1. Using pre-made buffer, put 1 mL of buffer in a 50 mL Falcon Tube and add 4 mL of
distilled water filtered through a 0.2µm syringe filter. Check the pH. This gives you
a working concentration of 153 mM
2. The desired pH is between 4.5-4.7. Under the fume hood, add 1 drop at a time of
concentrated HCl to the buffer, checking pH in between until desired pH is reached.
3. Once pH is reached, add 1 mL distilled water (sterile filtered through a 0.2µm syringe
filter as before). If pH is below 4.5, restart.
4. Weigh out an appropriate amount of STZ for the number of animals (see calculations
below) that will be injected in a 15 minute time frame.

Ex. Rats will be injected at 20mg/kg, so for 10 animals at an ideal weight of 200g
(avg. weight of rats to be injected), you will require a minimum of 40mg.
20mg/kg X 0.2kg = 4mg per animal
The amount of STZ weighed out should be more than the minimum as some solution
will be lost in filtering. (4mg (per animal) X 12 rats = 48mg total (0.048g)
5. Dissolve the STZ into buffer (keeping in mind a comfortable injection volume).
Shake to dissolve powder (approx. 1min). Sterile filter using a 0.2µm syringe filter.
Ex. 48mg STZ ÷ 3 mL buffer = 16mg/mL solution
4mg ÷ 16mg/mL solution = 0.25mL
6. STZ is time dependent and must be used within 5 minutes
Injecting and Follow-Up of the Animals
1. Promptly inject each rat with the solution (intraperitoneal) at a dosage rate of
20mg/mL (in this example, 0.25mL). Do not use anymore STZ solution more than 5
minutes after it has been dissolved in the sodium citrate buffer.
2. Dispose of any container having come into contact with the STZ (in either powder or
dissolved form) into a biohazardous waste receptacle. Dispose of needles into a
sharps container.
3. Return injected rats to their cage. Record the date of STZ injection and add a
biohazard label to the cage (leave biohazard label on cage for at least 3 days
following the last injection).
4. Repeat this procedure the following day.
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5. Check blood glucose daily. Diabetes is achieved with two non-fasting blood glucose
readings of >18 mmol Diabetes should be achieved after 5-8 injections (i.p.
20mg/kg).
Reference:
Low dose STZ induction protocol. Animal Models of Diabetic Complications
Consortium AMDCC Protocols.2003
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A2. Subcutaneous insulin pellet protocol
REVISION DATE: 13/06/2012
MATERIALS:
LinShin LinPlant Insulin Pellet
Rat anesthetic - Isoflurane
Ampicillin
Sterile water
1ml syringe with 25 g needle
10% providone-iodine solution
gauze (or swab)
Tissue forceps
Scalpel handle and blades (or scissors)
Silk suture
Needle drivers
EQUIPMENT:
Isofluorane Anaesthetic Machine
Hair clippers
Heat lamp
Special Safety:
Individual must wear lab coat and gloves before handling rodents. Any bite or scratch
that breaks the skin must be thoroughly scrubbed with soap and water (report to
Occupational Health and Safety, UWO).

PROCEDURE:
Pellet implantation (for a rat):
1. Anesthetize the animal using the isofluorane machine by placing it in the induction

chamber. Set isoflurane to 4-5% with an O2 flow rate of 1L/min. Open the stopcock
valve so gas reaches the chamber. Keep in chamber until the animal is unconscious.
2. Remove the animal and place its nose in the nose cone, reduce the isofluorane to 3%

to maintain the plane of anesthesia.
3. Shave the area where the pellet is to be implanted.
4. Using gauze (or a swab), apply 10% providone-iodine solution to the skin, followed

by 70% ethanol, to disinfect the site of insertion.
5. Hold the skin with forceps and make a subcutaneous incision.
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6. Cleanse a 12g trocar with 10% providone-iodine solution and insert it through the

puncture site to a depth of at least 2 cm.
7. Using forceps, briefly immerse the pellet in 10% providone-iodine solution, rinse

with saline and insert into the subcutaneous region.
8. Use 1 pellet for the first 350g of body weight.
9. Pinch the skin closed after the last pellet is inserted. Place a drop of 10 % providone-

iodine solution over the opening.
10. Close the incision by suturing.
11. Place the animal under a heat lamp and monitor until it recovers from anesthesia.
12. Record on the cage card that insulin pellets have been implanted.

Pellet removal:
1. Anesthetize the animal as described above for implantation.
2. Shave and palpate the area of implantation to locate pellets. Sterilize this area by

applying 10% providone-iodine solution followed by 70% ethanol.
3. Using a scalpel (or scissors), make an incision through the skin superficial to the

location of the pellets.
4. Using forceps, remove the pellet. Some connective tissue may need to be cut away

using scissors. Discard the pellet.
5. Close the incision by suturing.
6. Place the animal under a heat lamp and monitor until it recovers from anesthesia.
7. Record on the cage card that the pellets have been removed.

References:
http://www.linshincanada.com
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A3. Brain Histology and Orientation

A.3 Sagittal Section of the Rat Brain
Dashed lines illustrate the approximate location of initial transverse
sectioning of whole brains(17).

A.3 Transverse Section of the Rat rain.
The adapted image illustrates a prototype of the IHC sections.
Red dashed circles enclose area indicating the area of cerebral blood
vessel observation(19).
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A4. Histochemical Stains

Histological Visualization of Cerebral Vessels in H & E and LXFB across a spectrum of
magnification illustrates the anatomical region of cerebral vessels and delineates a small
cerebral vessel from a large cerebral vessel. It further delineates cerebral matter from the
adjacent vessels
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A5.Fluorescent Structural Comparison of Large versus Small Cerebral Vessels

For the purpose of the study, the vessels were separated into two sizes by their diameter
and their morphological appearance. The larger vessels were identified as arterioles that
encompassed 2-3 layers of smooth muscle cells and maintained a diameter range of about
0.135-0.14mm. The smaller vessels were identified as terminating arterioles with
roughly a single layer of smooth muscle and maintained a diameter range of about 0.040.05mm.
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A6. Immunofluorescence Localization Protocol
REVISION DATE: 19/6/2013
Proteins tested: Hsp70, Hsp90, iNOS, eNOS
Tissue tested: Paraffinized brain tissue:
Tissue Preparation:
Whole brains were extracted 72 hours post-last exercise training bout for trained or
following 10-week sedentary window.
Following which, brains were immediately placed in 4% paraformaldehyde renewed
daily for 72 hours and placed in 70% ethanol until tissue processing.
Brain tissues were transversally split-sectioned and embedded in paraffin, 10µm
transverse sections were mounted as pairs on frosted, poly-L-Lysine-coated, positively
charged microscope slides and stored at room temperature. Each slide held two serial
sections of the tissue in order to have negative controls.
Immunofluorescent (IHC)
IHC Day 1
1. Deparaffinize slides and antigen retrieved for approximately two hours with sodium
citrate buffer [10mM sodium citrate, 0.05% tween-20, pH 6.0]
2. Transfer slides to coplin jars and wash in 0.01% Tween-20 in PBS (T-PBS) for 5
minutes, followed by two washes in phosphate buffered saline (PBS, 1M) for 5
minutes each.
3. Following the washes dry slides with Kimwipe and double circle each tissue section
on the slide with a grease pen.
4. Block sections at room temperature with 10% goat serum in PBS for 1 hour in
humidity chambers
In the meantime, primary antibodies were thawed at room temperature and
assembled as cocktail dilutions of in 1% Tween-PBS (TPBS) goat serum.
5. The primary antibodies were combined as follows:
Hsp70: Rabbit polyclonal anti-hsp72 (SPA-812 StressGen) + mouse monoclonal
anti-alpha smooth muscle (ABCAM-18147).
Hsp90: Rabbit polyclonal to hsp90 (ABCAM-13495) + mouse monoclonal antialpha smooth muscle (ABCAM-18147).
iNOS: Rabbit polyclonal anti-iNOS (ABCAM-15323) + mouse monoclonal antialpha smooth muscle (ABCAM-18147).
eNOS: Rabbit polyclonal anti-eNOS/NOS Type III (BD Biosciences-610299) +
mouse monoclonal anto-alpha smooth muscle (ABCAM-18147).
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1° Antibody
Cocktails
Hsp70 + Smooth
Actin
Hsp90 + Smooth
Actin
iNOS + Smooth
Actin
eNOS + Smooth
Actin

Antibody Identifier

1° Antibody Concentration

Hsp70 (SPA-812)

1:100

Smooth α actin (AB18147)

1:400

Hsp90 (AB13485)

1:400

Smooth α actin (AB18147)

1:400

iNOS (AB 15323)

1:100

Smooth α actin (AB18147)

1:400

eNOS 1:100 (BD610299)

1:100

Smooth α actin (AB18147)

1:400

6. Following block, wash slides in PBS for three cycles of 5 minutes increment and dry
with Kimwipes. One out of two possible tissue sections on every slide incubate with
primary antibodies overnight in 4°celsius. The other section was incubated with 1%
TPBS goat serum in absence of primary antibodies in order to function as negative
controls to test for non-specific staining.
IHC Day 2:
7. Wash slides in PBS for three cycles of 5 minute increment and dry with Kimwipes,
following which incubate all sections secondary antibodies for 1 hour at room
temperature.
8. Make secondary Antibody Cocktail: Anti-mouse (1:400) + anti-rabbit secondary
(1:400) antibodies in 1% goat serum in T-PBS
2° Antibody Cocktail
Constituents
Anti-mouse
(Green fluorescence)
Anti-rabbit
(Red fluorescence)

Antibody Identifier
Alexa Fluor®488 Goat
Anti-Mouse IgG,
Invitrogen,
Alexa Fluor®594 Goat
Anti-Rabbit IgG,
Invitrogen

2° Antibody
Concentration
1:400

1:400

9. Following secondary incubation, wash slides in PBS for three cycles (5 minute
increments) and dry with Kimwipes.
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10. For the purpose of fluorescent imaging, mount slides with a fluorescent mounting
medium (Prolong® Gold Antifade Reagent containing DAPI, Invitrogen) containing
1% 4’, 6-diamidino-2-phenylindole (DAPI), a fluorescent nuclear stain and then
covered with glass cover slips (VWR® SuperSlips™ Micro Cover Glasses,
Rectangular, No. 1, 24 X 55mm, CA48382-128). In order to maintain the fluorescent
signal integrity and minimize photo bleaching, the store slides in a slide folder at 4˚C
until imaging.
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A7. Protein Abundance Acquisition
REVISION DATE: 19/06/2013
1.
The fluorescent bright field microscopy carried out on (Zeiss Axiovert S100) and
images were captured on Axiovert S100 at 16X and 40X magnification, using Northern
Eclipse 6.0 (Empix Imaging Inc) software.
2.
The protein content/abundance signal for Hsp70, Hsp90, iNOS and eNOS were
extracted as using Image J. Specifically, protein content was determined by outlining the
blood vessel of interest (D) and calculating the integrated pixel density (signal) using the
selection brush (B), on Image J and the same technique was used to determine the
integrated pixel density for the negative control of the same blood vessel.
3.
To obtain the relative protein density, the pixel density of the negative control was
subtracted from the pixel density of the experimental sample. The difference in pixel
density provided values that were used to indicate fluorescence signal intensity and thus
quantity of protein. For the collection of data for small and large vessels, this mode was
repeated for four blood vessels from the same animal and averaged to give a signal
protein value for the particular animal.
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A8.Smooth Muscle Area Calculations
For comparative analysis between vessel size and protein content, smooth muscle area
(SMA) was calculated for each vessel where the protein content was calculated. In
addition, SMA calculations allowed for protein content adjusted to the area.
The measures were collected from Image J. (A-B)
For SMA calculations, two full length perpendicular diameters from the outer perimeter
of each vessel (C) were averaged to obtain a diameter for the outer circle. Likewise, two
perpendicular diameters from the inner ‘endothelial’ perimeter of each vessel were
averaged to obtain a diameter for the inner circle(D). Both the diameters were
implemented to manually calculate the respective circular areas(E,F). The smaller circle
area (F) was then subtracted from the larger(E) circle in order to obtain the SMA for that
specific vessel(G).
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